You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endogenous glucose production

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial (HDV-Insulin Lispro)

Not yet recruiting
  • Type 1 Diabetes
  • HDV-Insulin Lispro
  • (no location specified)
Jan 9, 2023

Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Nicotinic acid, Placebo)

Recruiting
  • Type 2 Diabetes Mellitus
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jun 15, 2022

Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

Completed
  • Glycogen Storage Disease Type IA
  • [6,6-2H2]glucose
  • Groningen, Netherlands
    University of Groningen, UMC Groningen
Feb 10, 2022

Type 2 Diabetes Trial in Charlottesville (Metformin, Insulin Glargine, Dorzagliatin)

Recruiting
  • Type 2 Diabetes
  • Charlottesville, Virginia
    Rita Basu
Jul 19, 2022

End Stage Renal Disease Trial in Pisa (Empagliflozin, Placebo)

Completed
  • End Stage Renal Disease
  • Empagliflozin
  • Placebo
  • Pisa, Italy
    Department of Endocrinology and Metabolism, University of Pisa
Sep 13, 2021

Insulin Resistance Trial in Nashville (Trimethaphan, Saline)

Withdrawn
  • Insulin Resistance
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 3, 2021

Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Placebo
  • +3 more
  • San Antonio, Texas
    University Health System Texas Diabetic Institute
Apr 28, 2022

Type 2 Diabetes Trial (Pramlintide acetate, Placebo)

Withdrawn
  • Type 2 Diabetes
  • Pramlintide acetate
  • Placebo
  • (no location specified)
Jul 18, 2021

Type II Diabetes Trial in San Antonio (Dapagliflozin, Placebo)

Completed
Has Results
  • Type II Diabetes Mellitus
  • San Antonio, Texas
    University of Texas Health Science Center at San Antonio
Sep 15, 2020

Individual Variability in (Poly)Phenol Metabolism Trial in Parma (Coffee, Water)

Not yet recruiting
  • Individual Variability in (Poly)Phenol Metabolism
  • Coffee
  • Water
  • Parma, PR, Italy
    University of Parma - Plesso Biotecnologico Integrato
Aug 31, 2023

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin 10mg then Placebo Oral Tablet, Placebo Oral Tablet then Dapagliflozin 10mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Dapagliflozin 10mg then Placebo Oral Tablet
  • Placebo Oral Tablet then Dapagliflozin 10mg
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Sep 15, 2020

Type 2 Diabetes, Type 1 Diabetes Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
    Texas Diabetes Institute/UH
Jul 31, 2023

Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin

Completed
  • Type 1 Diabetes Mellitus
    • Leiden, Netherlands
    • +2 more
    Feb 24, 2022

    Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Placebo)

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • San Antonio, Texas
      University of Texas Health Science Center
    Aug 5, 2022

    Type1diabetes Trial in Huddinge (ProTrans)

    Active, not recruiting
    • Type1diabetes
    • Huddinge, Sweden
      Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitet
    Dec 17, 2021

    Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Placebo)

    Active, not recruiting
    • Type 2 Diabetes
    • +2 more
    • Bronx, New York
      Albert Einstein College of Medicine
    Nov 11, 2022

    Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

    Completed
    • Bariatric Surgery
    • Placebo
    • +3 more
    • Hvidovre, Denmark
    • +1 more
    Jan 31, 2022

    Morning Versus Afternoon Aerobic Exercise in Type 1 Diabetes

    Not yet recruiting
    • Type1diabetes
    • Morning exercise
    • Afternoon exercise
    • (no location specified)
    Nov 2, 2023

    Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • San Antonio, Texas
      University of Texas Health Science Center
    Sep 12, 2022

    Type1 Diabetes Trial in Stockholm (ProTrans: Allogeneic transplantation with WJMSCs, Placebos)

    Completed
    • Type1 Diabetes Mellitus
    • ProTrans: Allogeneic transplantation with WJMSCs
    • Placebos
    • Stockholm, Sweden
      Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitet
    Dec 17, 2021

    Obesity, Hypertension Trial in Nashville (Amlodipine, Moxonidine, Placebo)

    Recruiting
    • Obesity
    • Hypertension
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jun 8, 2022

    Lean Diabetes in Rural and Semi-urban India and in United States

    Completed
    Has Results
    • Malnutrition; Diabetes
    • Diabetes
    • Pancreatic Clamp
    • (no location specified)
    Nov 9, 2022

    Hypoglycemia Unawareness, Type 1 Diabetes, Healthy Trial in Philadelphia (RT-CGM)

    Active, not recruiting
    • Hypoglycemia Unawareness
    • +2 more
    • RT-CGM
    • Philadelphia, Pennsylvania
    • +2 more
    May 16, 2022

    Metabolic Syndrome Trial in Nashville (Low Salt diet plus Placebo tablet, Low Sodium diet plus Salt tablet, Epleronone)

    Completed
    Has Results
    • Metabolic Syndrome
    • Low Salt diet plus Placebo tablet
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Dec 30, 2020

    Renal Failure Trial in Pierre-Bénite (keto-analogs)

    Recruiting
    • Renal Failure
    • Pierre-Bénite, France
      Centre Hospitalier Lyon SUD
    Jul 5, 2021